| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5d8635485bf8ebf2ab2ccdbbacf8007 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-36134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-32 |
| filingDate |
2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cce2bc52d9d58903ffcd83d1d104c0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe9fb841d74751420e9505ac5aaa4f48 |
| publicationDate |
2018-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180043752-A |
| titleOfInvention |
Fusion protein and use thereof |
| abstract |
The present invention relates to a chitinoguania virus antigen protein and a toll-like receptor 5 stimulating protein, and to a use thereof, wherein the chikungunya virus envelope antigen protein according to the present invention In the case of diagnosing whether or not the virus is infected by using a fusion protein comprising plasgel, which is an etol-like receptor 5 stimulating protein, the antibody can be effectively detected in the blood to increase the sensitivity and accuracy in the diagnosis of the virus. In addition, the fusion protein can exert a remarkable synergistic effect when the immunogen induction through the vaccine is performed, as compared with the case where the fusion protein is inoculated with the chickungenya virus antigen protein alone. |
| priorityDate |
2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |